University of Georgia — Cassera Lab, Department of Biochemistry and Molecular Biology, Center for Tropical and Emerging Global Diseases (CTEGD)
Researchers in the Cassera Lab at the University of Georgia develop new antimalarial drug candidates and study how they work against malaria parasites, including drug-resistant forms.
What they do
Researchers in the Cassera Lab at the University of Georgia develop new antimalarial drug candidates and study how they work against malaria parasites, including drug-resistant forms.1 In collaboration with Dr. Paul Carlier's lab at the University of Illinois Chicago, they co-developed PRC1910 and related compounds, with PRC1910 demonstrating single-dose efficacy in mice and activity against both actively growing and dormant blood-stage parasites.1 The lab also investigates parasite metabolism and potential drug targets.1 Its U.S. R&D is based in Athens, Georgia, and its work spans discovery and development.1
- Athens, GA1Research and development
In the field and in development
Partnerships
No endemic-country partnerships are listed.
Who they work with in the United States
- In the atlas
Where this comes from
- 1Confirmed by the organization
- 2today.uic.edu
- 3ctegd.uga.edu